Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study
If you are ready to take a proactive step toward optimized health, energy, and longevity-focused wellness, our peptide and wellness offerings provide powerful tools to support your journey
For practical purposes, enhanced angiogenesis means faster granulation tissue formation in wounds, improved oxygen delivery to healing tendons and ligaments, and better nutrient supply to recovering muscles
Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
Role of OSGIN1 in mediating smoking-induced autophagy in the human airway epithelium